Alessandro Blasimme is a reader in bioethics at Swiss Federal Institute of Technology (ETH Zürich). He has held research appointments at the French National Institute of Health and Medical Research (INSERM) as well as the University of Zürich, before joining ETH Zürich. In 2013 he received a Fulbright-Schuman Scholarship to undertake research at the Program on Science, Technology and Society, Harvard University (USA) where he was a fellow. His research focuses on ethical and policy issues in biomedical innovation and biotechnology. His areas of expertise include translational medicine, precision medicine, regenerative medicine, genetic engineering, digital health and ageing. He has published widely in leading bioethics and medical journals and he is a principal investigator in national as well as international research consortia.
He is a visiting professor in bioethics at La Sapienza University of Rome (2022).